Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The herpesvirus helicase-primase complex is a critical multi-enzyme assembly composed of three subunits: a helicase (e.g., UL5 in HSV-1, pUL105 in HCMV), a primase (e.g., UL52 in HSV-1, pUL70 in HCMV), and a noncatalytic accessory protein (UL8 in HSV-1, pUL102 in HCMV)[1][2][4][5]. The complex unwinds the viral double-stranded DNA and synthesizes short RNA primers required for DNA polymerase-mediated genome replication[1][2][3][5]. Both subunits are essential for viral genome propagation, and inhibitors targeting the helicase-primase are under clinical development for treatment of drug-resistant or recurrent herpesvirus infections[3][6][7]. This complex is highly conserved across the Herpesviridae family, although structural and sequence differences underlie drug sensitivity variation among viral species[4].
Inhibition of helicase activity (blocks DNA strand unwinding); Inhibition of primase activity (prevents RNA primer synthesis for replication); Prevents viral DNA replication and proliferation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Herpesvirus helicase-primase complex (None established).